The nuclear protein PARP-1 [poly(ADP-ribose) polymerase-1] is activated in cardiomyocytes exposed to hypoxia causing DNA breaks. Unlike this stress-induced PARP-1 activation, our results provide evidence for Ca 2+ -induced PARP-1 activation in contracting newborn cardiomyocytes treated with growth factors and hormones that increased their contraction rate, induced intracellular Ca 2+ mobilization and its rhythmical and transient translocation into the nucleus. Furthermore, activated PARP-1 up-regulated the activity of phosphorylated ERK (extracellularsignal-regulated kinase) in the nucleus, promoting expression of the Elk1 target gene c-fos. Up-regulation of the transcription factor c-Fos/GATA-4 promoted ANF (atrial natriuretic factor) expression. Given that expression of ANF is known to be implicated in morphological changes, growth and development of cardiomyocytes, these results outline a PARP-1-dependent signal transduction mechanism that links contraction rate and Ca 2+ mobilization with the expression of genes underlying morphological changes in cardiomyocytes.
INTRODUCTION
Cardiomyocyte functioning is predominantly regulated by Ca 2 + mobilization in the cytosol. During contraction the sarcoplasmic reticulum serves as a reservoir from which Ca 2 + ions are released into the cytosol, whereas during relaxation Ca 2 + ions from the cytosol are sequestrated by the Ca 2+ -ATPase pump and its regulatory protein phospholamban into the sarcoplasmic reticulum lumen [1] [2] [3] . Release of Ca 2+ into the cytosol is dependent mainly on receptor-gated stores in the sarcoplasmic reticulum lumen, as well as on Ca 2+ entry through Ca 2+ channels in the cell membrane [4] .
We have described previously in neuronal cells, activation of the DNA-bound protein PARP [poly(ADP-ribose) polymerase]-1 by Ca 2+ released from IP 3 (inositol trisphosphate)-gated stores located in the nuclear envelope [5, 6] . PARP-1 is the most abundant member of the PARPs [7] , which catalyse a post-translational modification (polyADP-ribosylation) of nuclear proteins. This modification is initiated by ADP-ribose transferase activity and proceeds via polymerization of ADP-ribose moieties into longbranched negatively charged ADP-ribose polymers. PARP-1 activation takes part in DNA repair [8] , as well as in chromatin remodelling and gene expression by a variety of mechanisms [7] . One of them is polyADP-ribosylation of a prominent PARP-1 substrate, linker histone H1, which causes relaxation of the highly condensed chromatin structure, rendering the DNA more accessible to transcription factors and DNA repair enzymes [9] [10] [11] .
In addition to numerous findings indicating a pivotal role of DNA single-strand breaks in PARP-1 activation [7] , our previous findings in cell-free systems and in neuronal cells have disclosed an alternative mechanism of PARP-1 activation, which operates in the absence of DNA damage, and even in the absence of DNA [5, 6, 12, 13] . In cell-free systems, recombinant ERK2 (extracellular-signal-regulated kinase 2) and recombinant PARP-1 highly enhanced each other's activity. In addition, the activity of phosphorylated ERK in the nuclei of neuronal cells was up-regulated by polyADP-ribosylated PARP-1 [12] [13] [14] . These findings actually implicated the activation of PARP-1 in networks of signal transduction mechanisms activated by the MEK [MAPK (mitogen-activated protein kinase)/ERK kinase]/ERK phosphorylation cascade [5, 6, [12] [13] [14] [15] [16] . In neuronal cells, activated PARP-1 up-regulated ERK-catalysed phosphorylation of the transcription factor Elk1, thereby inducing core histone acetylation and the expression of Elk1 target genes [12] [13] [14] 17, 18] .
If PARP-1 activation in cardiomyocytes similarly up-regulates the Elk1 target gene c-fos, it may also up-regulate the formation of the transcription factor c-Fos/GATA-4, which is implicated in the response of cardiomyocytes to hormones and growth factors [19] [20] [21] . In the present paper, we examined this possibility. The enhancer/promoter region of the ANF (atrial natriuretic factor) gene contains several GATA-4-binding sites that are conserved among different species including rats, mice and humans [22] . ANF is expressed throughout embryonic and fetal development in both atrial and ventricular cardiac cells, and is essential for growth, differentiation and survival of cardiomyocytes [20] [21] [22] [23] . The growth of cardiomyocytes has been associated with the expression of the immediate early gene c-fos, the activity of GATA-4 and ANF expression [23] .
In the present study, we have examined the possibility that ANF expression in contracting cardiomyocytes of newborn rats Abbreviations used: ANF, atrial natriuretic factor; AngII, angiotensin II; ARBP, acidic ribosomal phosphoprotein; AT 1 , A ng II type 1; BAPTA/AM, 1,2-bis-(oaminophenoxy)ethane-N,N,N ,N -tetra-acetic acid tetrakis(acetoxymethyl ester); CBP, CREB (cAMP-response-element-binding protein)-binding protein; ChIP, chromatin immunoprecipitation; dbcAMP, dibutyryl cyclic AMP; dbcAMP, dibutyryl cAMP; DMEM, Dulbecco's modified Eagle's medium; ERK, extracellular-signal-regulated kinase; Iso, isoprenaline; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; PAR, poly(ADP ribose); PARP, poly(ADP-ribose) polymerase; rhod-2/AM, rhod-2 acetoxymethyl ester; siRNA, short interfering RNA; RT, reverse transcription. 1 To whom correspondence should be addressed (email marmon@post.tau.ac.il).
is mediated by the PARP-1-dependent up-regulation of c-fos expression, implicating Ca 2+ -induced activation of PARP-1 in a mutual up-regulation of PARP-1 and ERK activities in the nucleus of the cardiomyocyte.
EXPERIMENTAL Primary cultures of newborn cardiomyocytes
Cultures were prepared from cardiomyocytes obtained from the cardiac ventricles of 1-2-day-old Sprague-Dawley rats, essentially as described previously [24] . The cultures were seeded in collagen-coated six-well dishes and incubated in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % fetal bovine serum, 10 μg/ml transferrin, 10 μg/ml insulin, 100 μg/ml BSA and 1 % penicillin/streptomycin (Biological Industries), at 37
• C in a humidified atmosphere of 5 % CO 2 and 95 % O 2 . The cardiomyocytes were spontaneously contracting. Cells were exposed to growth factors or hormones in this buffer, after being kept for 24 h in DMEM deprived of all supplements except for 0.5 % fetal calf serum (starvation).
The newborn rats were handled in accordance with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (NIH Publication No. 85-23, revised 1996) . Approval for the present study was granted by the Tel-Aviv University Ethics Review Board.
Isolation of crude nuclei
Crude nuclei were isolated from lysed cardiomyocytes as described previously for brain cortical neurons [5, 25] . Briefly, cultured cardiomyocytes were washed with ice-cold PBS and homogenized on ice in isotonic sucrose solution containing 0.1 mM PMSF. Cells were lysed in a hypotonic solution (50 mM Tris/HCl, pH 7.4) containing 0.1 mM PMSF. Pellets obtained after centrifugation (900 g for 10 min at 4
• C) contained isolated crude nuclei (nuclei containing remnants of endoplasmic reticulum). The specific bands were scanned and quantified densitometrically using TINA version 2.09.
In situ immunofluorescent labelling of proteins in cultured cardiomyocytes
Cardiomyocytes were cultured on coverslips coated with collagen/gelatin. Anti-PAR polymer polyclonal antibody, diluted 1:300 (96-10-04; Alexis), was applied to cardiomyocytes that had been rapidly fixed by treatment for 10 min with icecold methanol/acetone (1:1, v/v) and thoroughly washed. After incubation for 2 h with the primary antibody at room temperature (25 • C), the cardiomyocytes were washed with PBS containing 0.1 % Tween 20 and exposed for 1 h at room temperature to the secondary fluorescent antibody [Jackson Dylight (green) and Cy TM 3 (red)]. PAR polymers formed on the nuclear proteins and phosphorylated ERK (Cell Signaling #9106) were detected by confocal microscopy.
Live imaging of intracellular Ca
2+ migration by a cell-permeant fluorescent Ca 2+ chelator (fluorophore)
The Ca 2+ fluorophore rhod-2/AM (rhod-2 acetoxymethyl ester) form was loaded (4.5 μM, incubation for 30 min at 25
• C in the dark) into cultured cardiomyocytes on collagen-coated glass coverslips. The fluorescence signals of Ca 2+ -bound rhod-2 (excitation wavelength 540 nm, emission wavelength >570 nm) were collected through appropriate filters above 520 nm and monitored by inverted confocal microscopy using a Zeiss LSM 410 equipped with a 25 mW krypton/argon laser (488 nm and 568 nm lines) and a 10 mW helium/neon laser (633 nm line). For imaging we used a Zeiss C-Apochromat 403 NA (numerical aperture) 1.2/water-immersion lens (Axiovert 135 M).
Examination of single-strand DNA breaks by alkaline gel electrophoresis
Examination of single-strand DNA breaks by alkaline gel electrophoresis provides a sensitive and rapid method for direct quantification of breaks in single strands of DNA [26] . DNA was isolated from the nuclei of cardiomyocytes using the Hirt procedure [27] . The migration of equivalent amounts of singlestranded DNA in 1 % alkaline agarose gel by electrophoresis [27] was detected by staining with 1 μg/ml ethidium bromide. Stained gels were photographed under UV illumination.
Hypoxic conditions
Cardiomyocyte cultures (5-7 days old) were washed from the medium with PBS containing 5 mM Hepes (pH 7.4) and transferred to glucose-free DMEM before exposure to hypoxia at 37.8
• C for 2-3 h. The cultured cardiomyocytes were placed in a hypoxic incubator in which the atmosphere was replaced by 100 % argon [28, 29] . In the present study, hypoxic damage in the treated cardiomyocytes was characterized by DNA single strand breaks.
Contraction frequency in treated cardiomyocytes
Contractility of the cardiomyocytes was measured by placing the culture dishes in a specially designed Plexiglas chamber, as described previously [30] . The chamber was placed on the stage of an inverted phase-contrast microscope (Olympus). Contractions of the cardiomyocytes, without or during stimulation, were measured using a video motion detector system. Analogue tracing was recorded with an oscilloscope connected through a specially designed interface to an IBM computer, and kinetic data were analysed as described previously [30] . The nucleotide sequences of the siRNA target sites in the PARP-1 gene corresponded to the sequences of rat PARP-1 cDNA. Two sequences comprising nucleotides 800-807 (5 -AAGAUAGA-GCGUGAAGGCGAA-3 ) and 890-897 (5 -AAGCCUCCGCC-CUGAACAAU-3 ) in the rat PARP-1 catalytic domain near the conserved active site were used to silence the expression of PARP-1. As a control we used the non-targeting siRNA #2 (Dharmacon #D-001810-10-05). In all experiments the cells were transfected with siRNA (100 nM) in serum-deprived medium using the X-tremeGENE siRNA transfection reagent (Roche Diagnostics #04-476-093-001). Changes in the expression of PARP-1 were measured 48-72 h after siRNA insertion.
RT (reverse transcription)-PCR profiling of relative expression levels of c-fos in stimulated rat cardiomyocytes
Expression of the c-fos gene was assessed by RT of nucleotides 1734-1853 in c-fos, using the forward primer 5 -GTTCCTGGCAATAGTGTGTTC-3 and the reverse primer 5 -G-CTGAAGAGCTACAGTAGTG-3 . RNA was prepared (RNeasy Mini Kit, Qiagen) 15, 30, or 60 min after treatment with 1 μM AngII (angiotensin II) for 10 min at 37
• C. RNA samples were treated with DNAse-I (Ambion #1906) to avoid the presence of DNA residues. cDNA was prepared from the RNA samples with the aid of SuperScript II kit (Invitrogen, #48-90-01,). Primer pairs underwent preliminary testing by conventional RT-PCR on one strand of the cDNA samples. RT-PCR was assayed (cycling program: 95
• C for 15 s, 60
• C for 30 s and 72
• C for 30 s) with the aid of the 7300 PCR System and the SYBR Green PCR Master Mix (Applied Biosystems). After RT-PCR, the dissociation curve was analysed to confirm that a single gene product was synthesized. The relative quantities of c-fos per sample were calculated in relation to each of two reference genes in rat S14 (hepatic lipogenic S14 protein [31] ; 5 -TCCTCTCCGTATGC-AGCCATGT-3 and 3 -ACCCTTCCTTCGAGTGCTGTCA-5 ), ARBP (acidic ribosomal phosphoprotein [32] ; 5 -CTGACTAC-ACCTTCCCACTG-3 and 3 -TCCGACTCTTCCTTTGCTTC-5 ) and GAPDH (glyceraldehyde-3-phosphate dehydrogenase; 3 -CTGGAAAGCTGTGGCGTGATGG-5 and 5 -TCCTCAG-TGTAGCCCAGGATGC-3 ) [33] using the C t formula as described previously [34] .
ChIP (chromatin immunoprecipitation) assay
Using the ChIP assay [35] we were able to detect c-Fos, GATA-4, CBP and acetylated core histone H4 adjacent to the promoter of the expressed ANF gene in myocytes treated by stimulation activating PARP-1 and MEK/ERK phosphorylation. In our protocol, proteins in the chromatin of cultured cardiomyocytes were cross-linked to DNA by formaldehyde (1 % formaldehyde for 10 min). This reaction was stopped by addition of glycine (125 mM for 5 min). Cardiomyocytes were then scrapped, dispersed in solution containing 1 % SDS and protease (Sigma #P8340), phosphatase (sodium orthovanadate) and deacytelase (sodium butirate) inhibitors, and sonicated (Probe sonicator 1000 W, 20 kHz, 15 cycles of 15 s, power set 3, 1 min intervals) on ice to obtain DNA fragments (400-600 b.p. average size). Proteins and transcription factors crosslinked to promoters in the DNA fragments were detected by immunoprecipitation with acetylated histones. The coimmunoprecipitated promoter of ANF with acetylated histone H4 was identified by PCR amplification. The transcription factor cFos/GATA-4 recruited to the ANF promoter was identified by co-immunoprecipitation with acetylated histone H4 and PCR amplification. Two nucleotide sequences in the ANF promoter were co-immunoprecipitated with acetylated histone H4: 5 -GCCTTTGTCCGTCACTGTCT-3 and 5 -GAGCGCCCAGG-AAGATAACC-3 for the promoter's proximal region and 5 -AAAGCGGTTTCATCCTCCAGGC-3 and 5 -ACAGGCTCT AAAGAATTCAGCTACACG-3 for its distal region.
RESULTS

Mobilization of intracellular Ca
2+ induces PARP-1 activation in stimulated contracting cardiomyocytes of newborn rats Confocal scanning of live cardiomyocytes was performed after application of 1 μM AngII to primary cell cultures of cardiomyocytes on collagen-coated coverslips. These cardiomyocytes were first exposed to the cell-membrane-permeant calcium fluorophore rhod-2/AM. Live confocal scanning revealed fluorescent sparks in the cells, indicating mobilization of Ca In view of previously reported evidence for Ca 2+ -induced PARP-1 activation in neuronal cells [5] (Figure 3) . A possible effect of ryanodine-dependent Ca 2+ mobilization on PARP-1 activation was examined as well. We did not observe any significant change in PARP-1 activation induced by ryanodine applied to isolated nuclei (Supplementary Figure S2) .
We then examined the possible effect of treatments inducing Ca 2+ mobilization from internal Ca 2+ stores on autopolyADP-ribosylation of PARP-1. In these experiments, cardiomyocytes were treated with AngII and α-and β-adrenergic agonists, as well as with dbcAMP (dibutyryl cAMP) and forskolin causing cAMP elevation. Figure 4A ). In addition, AngII-induced PARP-1 activation was suppressed by PARP-1 activation was also examined in cardiomyocytes treated with α-and β-adrenergic agonists or with dbcAMP, known to induce intracellular Ca 2+ mobilization [37] [38] [39] [40] [41] . A direct effect of cAMP elevation on PARP-1 activation was 32 P]polyADP-ribosylation in nuclear protein extracts. Nuclei were isolated from cardiomyocytes that were exposed for 10 min to the indicated α-or β-adrenergic ligands: the α-adrenergic agonist phenylephrine (Phen) and the specific β-agonist Iso, in the absence or presence of the α-adrenergic antagonist prazosin (Praz), or the β-adrenergic antagonist propranolol (Prop). [ 32 P]polyADP-ribosylated PARP-1 was autoradiographed and immunolabelled in each sample. Treatment with 50 μM BAPTA/AM interfered with PARP-1 auto-[ 32 P]polyADP-ribosylation by both adrenergic agonists. The histogram shows the means + − S.E.M. calculated from the results of three independent experiments. (D) DNA damage was not detected in the treated cardiomyocytes. DNA was isolated from cardiomyocytes treated with the indicated agents. Single-stranded DNA prepared from the nuclei of treated cells (DNA mounted on denaturating alkaline agarose gel electrophoresis) was analysed for nick formation. For comparison, a DNAse-treated DNA sample was mounted on the alkaline agarose gel as indicated. DNA fragments were detected after staining with ethidium bromide (1 μg/ml) under UV light. Markers: 1 kb DNA ladder (Sigma). Cont., control.
measured in cardiomyocytes treated with the cell-permeant derivative of cAMP dbcAMP [40] . PARP-1 was [
32 P]polyADPribosylated in the nuclei of cardiomyocytes treated with dbcAMP ( Figure 4B ) and in nuclei of cardiomyocytes treated with α-or β-adrenergic agonists ( Figure 4C ). Application of specific adrenergic antagonists suppressed the activity of PARP-1 ( Figure 4C) . Also, PARP-1 activation was suppressed by intracellular Ca 2+ depletion, achieved either by insertion of the cell-permeant Ca 2+ chelator BAPTA/AM or by exposing the cells to the Ca 2+ chelator EGTA [41] . These results further supported a linkage between stimuli that induce mobilization of intracellular Ca 2+ and activation of the nuclear protein PARP-1 in contracting cardiomyocytes (Figures 3 and 4) .
Treatments with AngII, α-and β-adrenergic agonists or compounds inducing cAMP elevation were not accompanied by single-strand breaks in the DNA ( Figure 4D ). This excluded a (A) DNA damage was measured in cardiomyocytes exposed to hypoxia during 3 h. Hypoxia was achieved by exchanging the atmosphere in the incubator with 100 % Argon. DNA was isolated from untreated cardiomyocytes (lanes 1 and 3) and from cardiomyocytes exposed to hypoxia (lanes 2 and 4). Their DNA was examined by agarose gel electrophoresis (lanes 1 and 2) and by denaturating alkaline agarose gel electrophoresis (lanes 3 and 4) . Double-strand and single-stranded breaks (lanes 1 and 2, and 3 and 4 respectively) were identified under UV light after staining with ethidium bromide (1 μg/ml). (B) Effects of hypoxia on PARP-1 activation in cardiomyocytes treated with Iso (10 μM) or AngII (1 μM) were assayed by measuring [ 32 P]polyADP-ribosylated PARP-1 in nuclei prepared from untreated cardiomyocytes (control, lane 1), from cardiomyocytes exposed to hypoxia without (lane 2), or while treated with Iso alone or in the presence of the β-adrenergic antagonist propranolol (Prop; 10 μM) (lanes 3 and 4 respectively), and from cardiomyocytes treated with AngII in the absence or in the presence of the modified AngII peptide H-1725 (100 μM) (lanes 5 and 6 respectively). Nuclei were isolated from the treated cardiomyocytes, incubated with [ possible activation of PARP-1 by these compounds due to DNA nicks formation in the treated cardiomyocytes.
Treatments with AngII, α-and β-adrenergic agonists and compounds inducing cAMP elevation activate signal transduction mechanisms targeting PKC (protein kinase C) and MAPK [42, 43] . On the basis of our results in a cell-free system, indicating an alternative mechanism of PARP-1 activation by phosphorylated ERK2, which operates only in the absence of DNA damage [12, 13] , we examined the possibility of a similar mechanism operating in cardiomyocytes. We first examined the effects of AngII and Iso in cardiomyocytes exposed to 3 h of hypoxia, which induced single-strand breaks in their DNA ( Figure 5A ). As expected, PARP-1 was activated in nuclei of cardiomyocytes exposed to hypoxia ( Figure 5B ). However, neither Iso nor AngII induced a further activation of PARP-1 ( Figure 5B ), in accordance with our findings in cell-free systems and in cerebral neurons, where DNA damage interfered with PARP-1 activation by phosphorylated ERK2 [12] . We therefore examined whether AngII-or Iso-induced PARP-1 activation is mediated by ERK phosphorylation in contracting newborn cardiomyocytes.
Interplay between PARP-1 activation and ERK phosphorylation in contracting cardiomyocytes
We examined by confocal imaging of fixed cells whether the fluorescent immunolabelling of activated PARP-1 colocalizes with the fluorescent labelling of phosphorylated ERK in nuclei of cardiomyocytes treated with AngII, Iso or dbcAMP. Co-localization of PAR polymers (indicating PARP activity, mainly the activity of PARP-1 [8] ) and phosphorylated ERK co-localized in the nuclei of treated cardiomocytes ( Figure 6A ). Furthermore, PARP-1 activation was suppressed by MEK inhibitors (Figure 6B ), in line with the previously reported activation of recombinant PARP-1 by recombinant phosphorylated ERK in cell-free systems [12] . Moreover, phosphorylated ERK decayed rapidly after suppressing the expression of PARP-1 by targeted siRNA in nuclei of AngIItreated cardiomyocytes (Figures 6C), in line with a suggested up-regulation of the activity of phosphorylated ERK in the nucleus by polyADP-ribosylated PARP-1, possibly acting as an anchoring protein of phosphorylated ERK [12, 13] . This suggested mechanism was supported further by down-regulation of cFos protein levels after PARP-1 silencing with PARP-1-targeted siRNA ( Figure 6C) .
ERK-catalysed phosphorylation of the transcription factor Elk1 up-regulates the HAT (histone acetyltransferase) activity of p300/CBP, resulting in acetylation of core histones and the expression of several immediate early genes including c-fos. The non-stable product c-Fos is mainly stabilized by ERKinduced phosphorylation [17, 18] . In view of the effect of PARP-1 silencing on phosphorylated ERK1/2 in the nucleus ( Figure 6C ), we examined the possibility that PARP-1 and PARP activation also affect the expression of the Elk1 target gene c-fos in cardiomyocytes.
PARP-1 activation mediates the expression of the immediate early gene c-fos in AngII-treated cardiomyocytes
Enhanced c-fos expression was measured within 30 min after stimulation in cardiomyocytes exposed to 1 μM AngII for 10 min. As expected, c-fos expression, which is mainly induced by the ERK-catalysed phosphorylation of the transcription factor Elk1, was down-regulated in cardiomyocytes treated with the specific MEK inhibitor U0126 which suppresses the phosphorylation of ERK1/2 ( Figure 7A) . However, the expression of c-fos was also suppressed by PARP inhibition or by silencing of PARP-1 with PARP-1-targeted siRNA (Figure 7) , providing evidence for PARP-1 in the ERK/Elk1-induced signal transduction mechanism. Furthermore, c-fos expression was down-regulated by BAPTA/AM, implicating Ca 2+ mobilization in c-fos expression. These findings suggest a mechanism up-regulating the expression of c-fos by simultaneous Ca 2+ mobilization, and ERK and PARP-1 activation.
In cardiomyocytes, a long-lasting ERK activity in the nucleus enabling ERK-induced phosphorylation (and thereby stabilization) of c-Fos protein [17] could up-regulate the activity of the transcription factor c-Fos/GATA-4 [20] [21] [22] [23] . We next examined the possible role of PARP-1 and PARP activity in c-Fos/GATA-4-induced gene expression.
PolyADP-ribosylation mediates c-Fos interaction with GATA-4 and with the ANF promoter in AngII-treated cardiomyocytes
Relatively large amounts of c-Fos were detected 80 min after treatment of cardiomyocytes with 1 μM of AngII ( Figure 8A ). Also, depending on PARP activity (polyADP-ribosylation is mainly attributable to PARP-1 activation [8] ), c-Fos coimmunoprecipitated with GATA-4 in nuclear protein extracts isolated from AngII-treated cardiomyocytes; PARP inhibition down-regulated the amount of c-Fos co-immunoprecipitated with GATA-4 ( Figure 8B ), presumably interfering with the formation of the transcription factor c-Fos/GATA-4 [23, 44] . We examined further whether polyADP-ribosylation is required for the expression of the c-Fos/GATA-4 target gene ANF. This possibility was examined by using a ChIP assay. Cross-linkage of c-Fos with GATA-4 and with the ANF promoter was examined 1 h after application of 1 μM AngII to cardiomyocytes that were than treated with 1 % formaldehyde to achieve cross-linking of DNA to proteins in the chromatin (see the Experimental section). These experiments revealed that the proximal region of the ANF promoter, which contains binding sites for GATA-4 [19, 44, 45] , co-immunoprecipitated with c-Fos in the crosslinked chromatin segments (400-600 b.p.) prepared from nuclear extracts of the treated cardiomycytes. Inhibition of PARP activity by 10 μM PJ-34 interfered with their co-immunoprecipitation ( Figure 8B ). Furthermore, cross-linkage of the promoter of ANF with acetylated histones would suggest a potential expression of ANF in AngII-treated cardiomyocytes. We examined the coimmunoprecipitation of the ANF promoter with acetylated core histones, and found that both the proximal and the distal regions of the ANF promoter co-immunoprecipitated with acetylated core histone H4 in the cross-linked chromatin segments that were prepared from AngII-stimulated cardiomyocytes ( Figure 8C ). Inhibition of PARP-1 by application of 10 μM PJ-34 to the cardiomyocytes 30 min before they were treated with AngII interfered with the co-immunoprecipitation of acetylated histone H4 with the ANF promoter, both with its proximal and its distal regions ( Figure 8C ). PARP inhibition also interfered with the co-immunoprecipitations of PARP-1, phosphorylated ERK2, Elk1, CBP, GATA-4 and c-Fos with acetylated core histone H4 ( Figure 8D ), suggesting that polyADP-ribosylation either mediated histone acetylation [12] or was required for the assembly of these proteins adjacent to acetylated H4 in response to treatment with AngII. In line with these findings, we measured the increase in ANF protein in AngII-treated cardiomyocytes that was dependent on PARP-1 expression. The increase in ANF was immunodetected after treatment of cardiomyocytes with 1 μM AngII and it was suppressed after silencing of PARP-1 with PARP-1-targeted siRNA (cardiomyocytes were transfected for 72 h with 100 nM PARP-1-targeted siRNA) ( Figure 8E ). Taken together, the above findings indicate that PARP-1 activation up-regulated the expression of ANF in AngII-treated cardiomyocytes.
Evidence for PARP-1 activation mediating the formation of the transcription factor c-Fos/GATA-4 and promoting ANF expression (Figures 7 and 8 ) outlines a pattern of signal transduction mechanisms activated by Ca 2+ mobilization and Ca 2+ -induced PARP-1 activation in the absence of DNA damage (Figures 1-5) , causing a mutual up-regulation of PARP-1 and ERK activities in the nucleus (Figure 6 ). Evidence for a positive-feedback mechanism keeping both PARP-1 and ERK2 activated were detected in cell-free systems [12] . The suggested signal transduction mechanisms in cardiomyocytes linking ANF expression to Ca 2+ -induced PARP-1 activation are shown in Figure 9 .
DISCUSSION
The present study provides evidence indicating the operation of signal transduction pathways that couples Ca 2+ -induced PARP-1 activation to ANF expression in stimulated contracting cardiomyocytes of newborn rats. Brief exposure of cultured cardiomyocytes to 1 μM AngII induced an accelerated rate of contraction accompanied by intracellular Ca 2+ mobilization and a rhythmical transient translocation of Ca 2+ into the cell nuclei accompanying their contractions (Figures 1 and 2 and Supplementary Figure S1 and Movie S1). We also found that PARP-1 is auto-polyADP-ribosylated in isolated nuclei of cardiomyocytes exposed to elevated extra-nuclear Ca 2+ concentrations (Figure 3 ), suggesting a Ca 2+ -mediated AngII-induced PARP-1 activation ( Figure 4A ). PARP-1 was similarly activated by treatments inducing mobilization of intracellular Ca 2+ , including exposure to adrenergic stimulation (with α-and β-adrenergic agonists) or elevated cAMP, and Ca 2+ chelators interfered with the activation of PARP-1 ( Figures 4B and 4C) . A similar activation of PARP-1 via Ca 2+ release from perinuclear stores into the nucleoplasm was reported previously in depolarized cerebral neuronal cells [5] . Mobilization of Ca 2+ did not induce DNA damage in either of these cell types ( Figure 4D ), excluding a possible PARP-1 activation by AngII and Iso, and elevated cAMP due to nick formation in the DNA [5, 12] . Furthermore, PARP-1 activation in cardiomyocytes exposed to hypoxia-inducing DNA singlestrand breaks was not activated by AngII (1 μM) or Iso (10 μM) ( Figure 5 ), in accordance with previously reported DNAindependent mechanism of PARP-1 activation in cell-free system [12] .
In addition, our results provided evidence for ERK phosphorylation coupled with the ensuing PARP-1 activation, which mediates the expression of the ERK target gene c-fos (Figures 6 and 7) . In cardiomyocytes, this linkage may further induce the up-regulation of ANF expression [20] [21] [22] 44] . By using a ChIP assay, we showed that activated PARP-1 up-regulated the formation of the transcription factor c-Fos/GATA-4 and ANF expression ( Figures 8A and 8B ). These findings are consistent with a signal transduction mechanism activated by signals inducing Ca 2+ mobilization from intracellular stores ( Figure 9 ). In cardiomyocytes, variations in the amplitude, frequency and compartmentalization of Ca 2+ signals are decoded by enzymes, ion channels and transcription factors operating via diverse signal transduction mechanisms [4, 40, 44, 46] . Previous results have suggested a variety of Ca 2+ -dependent mechanisms associating the rhythmical mobilization of Ca 2+ from intracellular stores with the regulation of cardiomyocyte contractility and growth [46] [47] [48] .
In the present study, our results identified a mechanism that couples ANF expression, which has a major role in cardiomyocyte development and survival [20] [21] [22] [23] , with Ca 2+ translocation and Ca 2+ -mediated signal transduction mechanisms activating PARP-1 and ERK interplay in the nucleus of newborn cardiomyocytes that are not exposed to hypoxia (Figures 5 and  9 ). Both PARP inhibition and PARP-1 silencing suppressed the expression of c-fos, thereby down-regulating the formation of the transcription factor c-Fos/GATA-4 and suppressing ANF expression in the stimulated cardiomyocytes (Figures 7 and 8 ). This suggested mechanism is in line with other findings indicating the role of perinuclear Ca 2+ in gene expression [39, [49] [50] [51] and with evidence for AngII-induced enlargement of cardiomyocyte size [52] , which was dependent on PARP activity [53] . These mechanisms are evidently part of a network of signal transduction mechanisms activating mutual effects of PARP-1 and phosphorylated ERK that were reported previously in cell-free systems [12] . GPCR, G-protein-coupled receptor; PARG, PAR glycohydrolase; pERK, phosphorylated ERK; PKA, protein kinase A; PLC, phospholipase C.
Accumulating findings in animal models and in humans indicate that accelerated pacing induces remodelling of the cardiac atria and ventricles [54] , sometimes leading to pathologies with poorly understood molecular mechanisms and high resistance to currently available drug therapy. The presented molecular mechanisms provide additional information on the cascade of events leading from malfunctioning to pathological changes in the morphology of cardiomyocytes.
